Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
Crossref DOI link: https://doi.org/10.1007/s40261-016-0465-0
Published Online: 2016-09-24
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Wei
Gong, Yang
Kuang, Meng
Wu, Peng
Cao, Chunxiang
Chen, Jinfei
Tang, Cuiju
Funding for this research was provided by:
The Project of Plans for the Development of Science and Technology of Nanjing, China (201208020)
License valid from 2016-09-24